key: cord-0792958-u1xh37qo authors: Barry, Gerald; McCarney, Catherine; Farrelly, Marc; Breathnach, Rory; Mooney, Carmel; More, Simon J. title: Rapid antigen testing for SARS-CoV-2 infection in a university setting in Ireland: Learning from a 6-week pilot study date: 2022-04-03 journal: Public Health Pract (Oxf) DOI: 10.1016/j.puhip.2022.100255 sha: 22891ea9b52e5bb56b9de32707f13523ede41528 doc_id: 792958 cord_uid: u1xh37qo OBJECTIVES: With the ongoing circulation of SARS-CoV-2 in countries across the world it is essential to identify effective ways to reduce the risk of infection while allowing society to function as close to ‘normal’ as possible. Serial testing using rapid lateral flow antigen tests is a possible way to do this by screening populations in a targeted way, identifying infectious (both symptomatic and asymptomatic) people and removing them from circulation while infectious. To make rapid antigen testing effective, high levels of participation are important. This study was designed to evaluate the establishment of a testing programme in a university setting and assess some of the factors that impact participation in such a study among both staff and students. STUDY DESIGN: Observational, survey. METHODS: A trial period of SARS-CoV-2 rapid testing using the Abbott Panbio rapid antigen test was set up and staff and students based in the University College Dublin Veterinary Hospital were asked to take part voluntarily for 6 weeks. Following the trial period, we used a questionnaire to evaluate satisfaction and to understand some reasons behind participation or lack thereof. RESULTS: Overall, almost all respondents to the survey stated that they were happy with having a testing programme present in the workplace and it helped to reduce anxiety associated with COVID-19. Findings indicated that staff and students did not participate equally in the voluntary testing programme. The findings also highlighted that intrinsic motivations and extrinsic motivations for participation differ. For example, participation among staff was much higher than among students, motivational messaging focused on protecting others did not resonate with students as much as staff, convenience was a key factor driving participation in both cohorts and the pressure of being forced to miss class (if positive) close to exam time provided motivation to students to avoid testing. CONCLUSIONS: Introducing antigen testing into a workplace helped to reduce overall anxiety associated with the potential impact of COVID-19, but achieving good participation was challenging. Participation is key to a successful, campus wide antigen testing programme but reaching high levels of participation is not straightforward and can not be taken for granted. Different motivations drive participation in different cohorts and different messaging/incentivisation is needed to encourage participation in those different cohorts. The findings reported here should inform any SARS-CoV-2 testing programme that will run in these types of settings in the future. symptomatic and asymptomatic) people and removing them from circulation while 10 infectious. To make rapid antigen testing effective, high levels of participation are 11 important. This study was designed to evaluate the establishment of a testing programme in 12 a university setting and assess some of the factors that impact participation in such a study 13 among both staff and students. 14 Study Design 15 Observational, survey 16 Methods 17 A trial period of SARS-CoV-2 rapid testing using the Abbott Panbio rapid antigen test was set 18 up and staff and students based in the University College Dublin Veterinary Hospital were 19 asked to take part voluntarily for 6 weeks. Following the trial period, we used a 20 questionnaire to evaluate satisfaction and to understand some reasons behind participation 21 or lack thereof. 22 Results 23 Overall, almost all respondents to the survey stated that they were happy with having a 24 testing programme present in the workplace and it helped to reduce anxiety associated with 25 COVID-19. Findings indicated that staff and students did not participate equally in the 26 voluntary testing programme. The findings also highlighted that intrinsic motivations and 27 J o u r n a l P r e -p r o o f extrinsic motivations for participation differ. For example, participation among staff was 28 much higher than among students, motivational messaging focused on protecting others did 29 not resonate with students as much as staff, convenience was a key factor driving 30 participation in both cohorts and the pressure of being forced to miss class (if positive) close 31 to exam time provided motivation to students to avoid testing. 32 Conclusions 33 Introducing antigen testing into a workplace helped to reduce overall anxiety associated 34 with the potential impact of COVID-19, but achieving good participation was challenging. 35 Participation is key to a successful, campus wide antigen testing programme but reaching 36 high levels of participation is not straightforward and can not be taken for granted. Different 37 motivations drive participation in different cohorts and different messaging/incentivisation 38 is needed to encourage participation in those different cohorts. The findings reported here 39 should inform any SARS-CoV-2 testing programme that will run in these types of settings in 40 the future. 41 42 The COVID-19 pandemic that started in China in late 2019 has caused disruption to the whole world 44 in one form or another. The betacoronavirus, SARS-CoV-2, that causes COVID-19, primarily transmits 45 between people in aerosol droplets, so close contact in poorly ventilated indoor environments are 46 areas of high risk of transmission if an infected person is present. In Ireland, as elsewhere, the 47 isolation of infectious individuals is central to efforts to limit SARS-CoV-2 transmission. People with 48 symptoms are asked to self-isolate, however, this does not remove the risk posed by pre-49 symptomatic and asymptomatic individuals. Pre-symptomatic transmission is known to be 50 substantial 1 and asymptomatic or mildly symptomatic individuals may also shed virus at levels 51 sufficient to infect others 2 . There is considerable heterogeneity in estimates of relatively 52 infectiousness of symptomatic and asymptomatic people, and no conclusive evidence of difference 3 . 53 Further, SARS-CoV-2 does not shed from infected people equally, with approximately 2% of infected 54 people carrying approximately 90% of the total virus load in a population at any one time. The 55 distribution of viral loads, by PCR test, cannot be distinguished according to symptoms suggesting 56 that people shedding large amounts of virus are as likely to be asymptomatic as symptomatic 4 . Viral 57 load is associated with increased likelihood to shed infectious virus, so those people with the most 58 J o u r n a l P r e -p r o o f virus in their upper respiratory tract are the most likely to infect others and to be associated with 59 superspreading events 5 . Collectively, in the context of effective disease control, these factors 60 highlight the need to identify those with the highest virus loads, regardless of their clinical 61 presentation. 62 Antigen-detecting rapid diagnostic tests (Ag-RDTs) offer a means to rapidly identify infected 63 individuals, with the potential to substantially reduce the risk of onward SARS-CoV-2 transmission. 64 However, like every diagnostic test, rapid antigen tests are not perfect and there are both strengths 65 and weaknesses with them. An Ag-RDTs using a lateral flow device (LFD) has a lower sensitivity than 66 PCR. In a detailed review, sensitivity of Ag-RDT was estimated to be 72.0% (95% confidence interval 67 63.7-79.0) and 58.1% (40.2-74.1) for symptomatic and asymptomatic individuals 6 , respectively, but 68 noting that sensitivity does vary between test manufacturers 7 and will be operator-dependent 8 . 69 Although Ag-RDTs have a higher risk of false negatives that PCR, infected people test positive by LFD The World Health Organisation recommends the use of Ag-RDTs in specific situations, including 77 outbreak investigation/contact tracing, monitoring trends in disease incidence, widespread 78 community transmission and to test asymptomatic contacts of cases (World Health Organisation, 79 2020). In contrast, the use of Ag-RDTs can be problematic in populations with low infection 80 prevalence and low pre-test probability. In these settings, the positive predictive values will be low 81 (leading to a high proportion of false positive results) when testing is conducted at large-scale 7 . In 82 situations where the pre-test probability is low-to-moderate, Ag-RDT results must be interpreted 83 with care. In these settings, a Ag-RDT positive should be considered preliminary, with individuals 84 isolating until a PCR test result is known. Ag-RDT negative individuals should continue to comply with 85 conventional risk mitigation measures 10 . Ag-RDTs will be most effective when used regularly, with 86 high levels of participation. 87 In the UK, Ag-RDTs have been used in universities, schools and care homes 11,12 to rapidly identify -88 and remove -those asymptomatic people who are shedding high amounts of virus. Early results 89 from a pilot at the University of Liverpool were disappointing, with approximately half of cases 90 missed (a sensitivity in comparison to the PCR of 48.9%, specificity of 99.93%) 11 . In Ireland, there is 91 processing plant workers, which is recognised as a high-risk setting. In these situations, once or 93 twice-weekly Ag-RDTs has been suggested as a viable alternative to once-monthly RT-PCR serial 94 testing, specifically with the aim to identify and isolate asymptomatic individuals 13 considered, given the serious national picture (7-day incidence, levels of community transmission), student rotations. As a consequence, and in the interests of business continuity, there was further 118 evaluation of final year teaching, changes to teaching timelines, the introduction of higher 119 specification face masks and the strategic placement of air purifying units. Further, as reported here, 120 a pilot study of testing using a Ag-RDT was conducted with veterinary hospital staff and students 121 over a 6-week period from 24 March to 29 April 2021, coinciding with a national 14-day incidence of 122 The Panbio TM COVID-19 Ag rapid test device (Abbott, Ireland) was used for all tests. The nasal test 134 swab was self-administered under supervision from a trained tester. Training videos and were also 135 provided in advance of the first day of testing. Swabs were then tested using a lateral flow device by 136 a trained tester independent of the person that had been swabbed. All test swabs were labelled with 137 a code so testers did not know who they were testing. 138 Testing was carried out each Monday and Thursday. A person being tested entered a designated 139 room, they were directed to a swabbing station, and they were then instructed how to perform the 140 swab. The swabbing was then observed to ensure correct technique before the swab was placed in a 141 test tube for analysis by the testing team. The swabber being tested was allowed to leave after being 142 swabbed and their swab was analysed within 30 minutes of the swab taking place. If the person was 143 negative, they were not contacted, but if they were positive, they were informed verbally as soon as 144 the result came through. A rubric for how a positive person should act after testing positive was 145 generated and used to guide candidates that tested positive. At the end of the 6-week trial, a link to an electronic survey (supplementary file 2) was sent by email 154 to all staff and students that could have taken part in the study. Importantly, this included both 155 those that participated and those that did not but were eligible to do so. people chose not to attend because they felt they were at low risk and didn't need to attend, and 181 others indicated that their time on campus was limited [11] Opportunities to increase participation. There were a total of 81 respondents to this question, and 185 answers can be grouped into the following 4 themes: 186 • Reminders: Many people indicated that a reminder on the day of the test would have been 187 useful. This could have come as a text message or an email, but forgetting to attend was 188 clearly an issue for many. 189 fellow workmates safer by getting tested, this was not incentive enough for many. With this 204 in mind, a number of respondents pointed out that incentives might encourage more 205 participation. Incentives such as the ability to use a testing certificate to be allowed to do 206 more things, partake in more activities. Other incentives such as sweets, a bottle of wine for 207 the most participation etc. were also mentioned. 208 The pilot study was implemented successfully, and a relatively large group of staff and students were 237 tested on a regular basis in a safe and efficient manner over the 6-week period. Further, as a result 238 of the trial, the participants reported a decrease in anxiety in the workplace and increased 239 confidence among workers. The testing programme allowed participants to carry out their work 240 aware that an extra layer of risk reduction was in place alongside other risk mitigations such as high-241 grade masks, physical distancing, hand cleanliness and increased ventilation. Importantly, the 242 introduction of the antigen testing was not associated with a noticeable decrease in people 243 following HSE guidelines around the other risk mitigations, so risk of a COVID-19 outbreak in the 244 workplace was decreased overall. 245 There was excellent feedback from staff and students in relation to the information they received 246 beforehand as well as the training videos. Nonetheless, the initial swabbing technique among 247 participants varied greatly, highlighting the importance of on-hand assistance for first-time 248 participants. Correct nasal swabbing technique will likely improve test sensitivity and it is vital that 249 this aspect is performed correctly every time. The current study found that after some initial one-to-250 one direction, technique became relatively uniform and efficient. 251 The strengths and weaknesses of rapid antigen tests were clearly highlighted to participants, 252 including prudent interpretation of test results. In particular, an understanding that while a positive 253 means that the individual is very likely to be infected and shedding virus, a negative test means that 254 virus was not detected at this point but it did not mean you aren't infected, and therefore one 255 should continue to follow all other public health guidelines. The major benefit of an antigen test is 256 that it will pick up highly infectious people efficiently and conveniently, but with the possibility of 257 missing infected people. This was clearly explained to participants in the information leaflet. These 258 messages have been informed by earlier experience of rapid antigen testing in Ireland, during 259 ongoing screening of asymptomatic people in meat processing plants in January 2021 13 should ideally be easy to perform, convenient and cheap. It should be cost-effective, and people 276 must be willing to submit to testing regularly. 277 In the staff cohort, participation levels were high (75-90 %) and commentary about the test was 278 generally very positive with regular use of words such as peace of mind, confidence and safe in the 279 survey. No concerns were raised about the test itself. In contrast, the participation in the student 280 group was very low (19%), which appears to be due to a number of contributing factors. Among 281 students, a common reason given in the survey and also verbally during the study, when queried, 282 was the fear of testing positive and the consequent impact on their studies. The timing of the pilot 283 study may have played a role in this anxiety, as it was the final few weeks of term before graduation, 284 with exams approaching and rotations in the hospital pending that needed completion. Nonetheless, 285 it is worrying that some people would place these concerns ahead of the benefit that would accrue 286 from a positive test result, including the reduction in infection risk, which could potentially be 287 devastating, for fellow staff and students. It would be informative to conduct a similar pilot study at 288 a different time of year, when similar pressures are not present (the start of the academic term for 289 example), to see if this issue dissipates. Another common reported issue was time. Although this was 290 a factor for both staff and students, students may have felt extra pressure, either consciously or 291 otherwise, to avoid missing time in hospital for the sake of a test. It is apparent, based on feedback 292 from both staff and students, that convenience is a priority and would help participants to 293 participate more regularly, particularly when time is at a premium. 294 Throughout the pilot study, messaging in support of participation had a strong public good element, 295 seeking to reduce infection risk both to the individual and their fellow classmates / workmates / 296 hospital as a whole. While this apparently worked well with staff, it did not appear to resonate with Presymptomatic 331 transmission of SARS-CoV-2 infection: a secondary analysis using published data SARS-CoV-2 335 Transmission from People without COVID-19 Symptoms Relative infectiousness of 339 asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid 340 scoping review −positive individuals carry 90% of the virus circulating in communities. Proceedings of the 344 National Academy of Sciences Transmissibility of 348 COVID-19 depends on the viral load around onset in adult and symptomatic patients. Pan X, 349 editor Rapid, point-of-care 352 antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection Considerations for Assessment and 356 Deployment of Rapid Antigen Tests for Diagnosis of COVID-19. Open Forum Infectious 357 Diseases Put to the test: Use of rapid testing technologies for 360 The BMJ Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays 363 Interim guidance IFCC interim 365 guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic 366 and symptomatic individuals. Clinical Chemistry and Laboratory Medicine Liverpool pilot data show Potential impact of different serial testing scenarios using RADTs to detect SARS-CoV-2 in 377 meat processing plant workers Health Information and Quality Authority Potential impact of 378 different serial testing scenarios using rapid antigen detection tests (RADTs) to CoV-2 in meat processing plant workers Testing for COVID-19: willful 381 ignorance or selfless behavior? Behavioural Public Policy How to make universal, voluntary 385 testing for COVID-19 work? A behavioural economics perspective. Health Policy J o u r n a l P r e -p r o o f the vast majority of students at our institution. The interplay between public good and private 298 benefit has been considered in several recent papers, with differing results. In a recent study from 299 the US, Thunström et al. (2021) found that healthy younger people were more likely to take a no-300 cost COVID-19 test than health older people, with people generally selfless in their decision to test 301 for COVID-19 14 . In contrast, Fallucchi et al. (2021) found that willingness-to-test was increased in 302 association with altruism, conformism and risk-aversion and decreased with decreasing age and 303 increased willingness to take risks 15 . Messaging tailored to our students with an emphasis on 304 personal benefits or rewards may have been more successful. Indeed, a bottle of wine was 305 suggested by one survey respondent or sweets for every swab by another. Incentives may be a way 306 to encourage participation in the student cohort and this is something that needs to be considered 307 going forward, although this would then have to be made available for staff too. 308 In conclusion, the trial showed that antigen testing could be carried out effectively and efficiently in 310 a university setting with a relatively large cohort, on a regular basis. The study also identified 311 differences in participation in the staff and student cohort, suggesting different approaches are 312 needed to incentivise different cohorts. Future studies will focus on promoting how a testing regime 313 can bring personal benefits to students, rather than emphasising the benefit of increasing safety to 314 others. Future work will also focus on convenience and the potential, for example, of running at 315 home testing and self-reporting rather than attending a testing centre. 316Because of the concern around participation, it could also be considered to deploy rapid testing 317 during times of case number surges only, rather than on a serial basis during times when case 318 numbers were stable or low. One could initially train large cohorts to carry out self-testing during 319 times when cases were low and if the need arose, because of a surge of cases in a concentrated 320 geographical area, test sites could be rapidly set up to test large numbers of people in a short space 321 of time. While not ideal theoretically, because regular testing would be better as a risk mitigation 322 strategy, practically, surge testing might be more feasible and cost effective. 323 324 Acknowledgements: 325We would like to thank University College Dublin for supporting this study. We thank all participants, 326 both students and staff of University College Dublin for taking part.